Koichi Homma

Title: Koichi Homma: Innovator in Radiopharmaceuticals

Introduction

Koichi Homma is a notable inventor based in Sodegaura, Japan. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative patent that addresses the stabilization of radiopharmaceutical compositions.

Latest Patents

Homma holds a patent for a stabilizer for radiopharmaceuticals. This patent describes a stabilized radiopharmaceutical composition, which includes a metal complex of a radionuclide with a ligand. The composition is designed to be resistant to either reductive degradation or radiolysis. It features a first stabilizer, which is an amino-substituted aromatic carboxylic acid or a salt, ester, or amide thereof. Additionally, a second stabilizer, which is a diphosphonic acid or salt thereof, is included. The stabilizers are present in effective amounts to ensure the stability of the radiopharmaceutical, which is not a metal complex of the diphosphonic acid. This innovation is crucial for enhancing the efficacy and safety of radiopharmaceuticals.

Career Highlights

Throughout his career, Koichi Homma has worked with prominent companies in the medical field, including GE Healthcare Limited and Nihon Medi-Physics Company, Limited. His experience in these organizations has allowed him to develop and refine his expertise in radiopharmaceuticals.

Collaborations

Homma has collaborated with notable professionals in his field, including Anthony Eamon Storey and Georg Brauers. These collaborations have contributed to the advancement of his work and the development of innovative solutions in radiopharmaceutical technology.

Conclusion

Koichi Homma's contributions to the field of radiopharmaceuticals through his patent and professional collaborations highlight his role as an influential inventor. His work continues to impact the medical industry positively.